Researchers explored data from more than 3,000 TAVR patients, presenting their results in JACC: Cardiovascular Interventions. 

Targeting immune cells that play a key role in the development of atrial fibrillation could give cardiologists a new way to treat the disease.

Early data suggest the new transcatheter tricuspid valve repair device could make a big impact on patient care, but additional research is still necessary. 

According to the FDA, a limited number of unaffected blood tests are available if providers are unable to identify a better way forward. 

The group collaborated with two other medical societies, SCAI and CHSS, on the expert consensus document. 

The 2023 Cardiovascular Business Salary and Job Satisfaction Report is here! We surveyed cardiologists, interventional cardiologists, nurses, service line mangers, coders and others in the industry about several topics, including compensation, burnout, EHRs and much more.

Researchers in Japan tracked BNP levels and bleeding events among more than 7,000 PCI patients. The group noted that managing heart failure in the first 30 days after PCI can help boost outcomes. 

The new-look devices are soft, flexible, transparent and roughly the size of a postage stamp.

The Rocky Mount, North Carolina-based facility is said to be responsible for producing 25% of Pfizer’s sterile injectables used by hospitals in the U.S.

The Ohio-based startup also recently scored $15M in funding from the Mayo and Cleveland clinics and GE Healthcare.